Cargando…
Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study
In this study, we explored the predictive value of serum microRNA (miRNA) expression for early tumor progression during FOLFIRINOX chemotherapy and its association with overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC). A total of 132 PDAC patients of all disease stages...
Autores principales: | van der Sijde, Fleur, Homs, Marjolein Y. V., van Bekkum, Marlies L., van den Bosch, Thierry P. P., Bosscha, Koop, Besselink, Marc G., Bonsing, Bert A., de Groot, Jan Willem B., Karsten, Thomas M., Groot Koerkamp, Bas, Haberkorn, Brigitte C. M., Luelmo, Saskia A. C., Mekenkamp, Leonie J. M., Mustafa, Dana A. M., Wilmink, Johanna W., van Eijck, Casper H. J., Vietsch, Eveline E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535910/ https://www.ncbi.nlm.nih.gov/pubmed/34681562 http://dx.doi.org/10.3390/ijms222010902 |
Ejemplares similares
-
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
por: van der Sijde, Fleur, et al.
Publicado: (2021) -
Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients
por: van der Sijde, Fleur, et al.
Publicado: (2022) -
Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study
por: van der Sijde, Fleur, et al.
Publicado: (2022) -
Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection
por: Vietsch, Eveline E., et al.
Publicado: (2019) -
Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma
por: Farshadi, Elham Aida, et al.
Publicado: (2021)